Mizuho Medy Co (TSE:4595) YoY EBITDA Growth : 22.01% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Mizuho Medy Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 22.01%.

Mizuho Medy Co's EBITDA per Share for the three months ended in Mar. 2024 was 円131.56.

Mizuho Medy Co YoY EBITDA Growth Historical Data

The historical data trend for Mizuho Medy Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co YoY EBITDA Growth Chart

Mizuho Medy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

2.21

-54.44

1,047.63

61.34

-52.64

Mizuho Medy Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-62.56	-52.18	-54.23	-43.41	22.01

Mizuho Medy Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Mizuho Medy Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(561.474	-	1185.511)	/	\| 1185.511 \|
=	-52.64 %

Mizuho Medy Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(131.562	-	107.833)	/	\| 107.833 \|
=	22.01 %

Mizuho Medy Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Mizuho Medy Co (TSE:4595) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048

Website

http://www.mizuho-m.co.jp

Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines